Mankind Pharma cuts stock-outs 75% with AI-driven supply chain model

Mankind Pharma, an Indian pharmaceutical company, faced stock-outs — a failure mode with consequences far beyond lost revenue. Pharmaceutical supply chains carry compounding complexity: strict regulatory requirements, cold-chain logistics, expiration date management, and demand that spikes sharply in response to disease outbreaks and seasonal illness patterns. Traditional forecasting methods often fall short when these variables intersect.

Mankind Pharma implemented an AI-driven supply chain optimization model.

Following implementation, Mankind Pharma achieved a 75% reduction in stock-outs.

Key outcomes:

• 75% reduction in stock-outs
• Maintained regulatory compliance

• Incorporate external demand signals. Pharma demand forecasting that factors in disease outbreaks and seasonal trends can predict demand more accurately than models relying only on historical sales.
• Dynamic reorder-point adjustment is especially valuable in pharmaceutical distribution, where excess inventory has to be balanced against the need for product availability.
• Start with the highest-volume or most-critical SKUs. They typically have enough data history for reliable forecasts, and a proven concept can then expand to broader product categories.
• Plan for change management alongside the technology. AI recommendations frequently appear counterintuitive to experienced planners; structured review processes preserve human judgment while capturing algorithmic gains.
• Integration with existing ERP and warehouse management systems is crucial. The goal is to enhance current workflows rather than replace the technology stack.